Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 6”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Large-scale testing (Phase 3)Active Not RecruitingNCT06709014
What this trial is testing

Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who this might be right for
Early Alzheimers Disease
Annovis Bio Inc. 760
Large-scale testing (Phase 3)Active Not RecruitingNCT05738486
What this trial is testing

Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Who this might be right for
Alzheimer's DiseaseDementiaBrain Diseases+5 more
Eli Lilly and Company 1,175
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Large-scale testing (Phase 3)Ended earlyNCT00954590
What this trial is testing

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer
Medivation, Inc. 89
Not applicableStudy completedNCT02978768
What this trial is testing

Tai Chi 6-Form Sports Apparatus With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Chang Gung Memorial Hospital 67
Large-scale testing (Phase 3)WithdrawnNCT01211782
What this trial is testing

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Who this might be right for
Alzheimer's Disease
Cerecin
Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Not applicableLooking for participantsNCT07835399
What this trial is testing

Efficacy and Safety of Photobiomodulation Therapy in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Alzheimer DiseaseDementia
Jun Xu 20
Early research (Phase 1)WithdrawnNCT03635879
What this trial is testing

Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

Who this might be right for
Alzheimer Disease
Cerecin
Not applicableStudy completedNCT04916886
What this trial is testing

A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.

Who this might be right for
COVID-19
CanSino Biologics Inc. 2,021
Not applicableStudy completedNCT01312363
What this trial is testing

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients

Who this might be right for
Alzheimer's Disease
Seoul National University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Early research (Phase 1)Study completedNCT00975481
What this trial is testing

Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT01522404
What this trial is testing

Effects of Atomoxetine in Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Emory University 39
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Large-scale testing (Phase 3)Study completedNCT00277810
What this trial is testing

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 250
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Not applicableStudy completedNCT04466735
What this trial is testing

BRain Energy Activation With Ketones to Prevent Alzheimer's Disease

Who this might be right for
MCI
Université de Sherbrooke 65
Not applicableLooking for participantsNCT06810960
What this trial is testing

A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 3,000
Next Page